Pituitary adenylate cyclase-activating polypeptide

Progress in Biochemistry and Biophysics

Volumn 28, Issue 2, 2001, Pages 142-144

  Li, Xi Long ^a   Zhao, Xin Xu ^b  

^a KUNMING INSTITUTE OF ZOOLOGY   (China)

^b GANSU AGRICULTURAL UNIVERSITY   (China)

Author keywords

Neuropeptide; Pituitary adenylate cyclase activating polypeptide; Receptor; Vasoactive intestinal peptide

Indexed keywords

EID: 21944447125     PISSN: 10003282     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Miyata A, Arimura A, Dahl R R, et al. Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells. Biochem Biophys Res Commun, 1989, 164 (1): 567-574
2. Arimura A. Piruitary adenylate cyclase activating polypeptide (PACAP): discovery and current status of research. Regul Pept, 1992, 37 (3): 287-303
3. Chanel N, Tonon M C, Vaudry H. Primary structure of frog pituitary adenylate cyclase activing polypeptide (PACAP) and effects of ovine PACAP on frog pituitary. Endocrinology, 1991, 129 (6): 3367-3371
4. Arimura A. Receptors for pituitary adenylate cyclase activating polypeptide, comparison with vasoactive intestinal peptide receptors. Trends Endocrinol Metab, 1992, 3 (8): 288-294
5. Solano R M, Carmena M J, Busto R, et al. Identification and functional properties of the pituitary adenylate peptide (PAC1) receptor in human benign hyperplastic prostate. Cell Signal, 1999, 11 (11): 813-819
6. Braas K M, May V. Pituitary adenylate cyclase activating polypeptide directly stimulate sympathetic neuron neuropeptide Y release through PAC1 receptor isoform activation of specific intracellular signaling pathway. J Biol Chem, 1999, 274 (39): 27702-27710
7. Dickinson T, Mitchell R, Robberecht P, et al. The role of VIP/PACAP receptor subtyjpes in spinal somatosensory processing in rats with an experimental peripheral mononeuropathy. Neuropharmacology, 1999, 38 (1): 167-180
8. Magali B, Bruno J G, Laurence D, et al. Pituitary adenylate cyclase activating polypeptide (PACAP) stimulates adenylyl cyclase and phospholipase C activity in rat cerebellar neuroblasts. J Neurochem, 1995, 65 (3): 1318-1324
9. Daniel T C, Xlaohual C, Sassaroli M, et al. Pituitary adenylate cyclase activating polypeptide regulates prolactin promoter activity via a protein kinase A-mediated pathway that is independent of the transcriptional pathway employed by thyrotropin releasing hormone. Endocrinology, 1996, 137 (4): 1276-1285
10. Yamaguchi N, Lamouche S. Enhanced reactivity of the adrenal medulla in response to pituitary adenylate cyclase activating polypeptidel-27 (PACAP) during insulin induced hypoglycemia in anesthetized dogs. Can J Physiol Pharmacol, 1999, 77 (10): 819-826
11. + influx dependent membrane depolarization in bovine adrenal chromaffin cells. Endocrinology, 1996, 137 (3): 956-966
12. Hurley J D, Gardiner J V, Jines P M, et al. Cloning and molecular characterization of complementary deoxyribonucleic acid corresponding to a novel form of pituitary adenylate cyclase activating polypeptide messenger ribonucleic acid in the rat testis. Endocrinology, 1995, 136 (2): 550-557
13. West A P, Mckinnell C, Sharpe R M, et al. Pituitary adenylate cyclase activating polypeptide can regulate testicular germ cell protein synthesis in vitro. J Endocrinol, 1995, 144 (2): 215-223
14. EL-Gehano F, Zhang F P, Pakarinen P, et al. Gonadotropin-independent regulation of steroidogenesis in the fetal rat testis. Biol Reprod, 1998, 58 (1): 116-123
15. Romanelli F, Fillo S, Isodori A, et al. Ptuitary adenylate cyclase activating polypeptide regulates rat leydig cell function in vitro. Neuropeptides, 1997, 31 (4): 311-317
16. Ko C, In Y H, Park-Sarge O K. Role of progesterone receptor activation in pituitary adenylate cyclase activating polypeptide gene expression in rat ovary. Endocrinology, 1999, 140 (11): 5185-5194
17. Guijarro L G, Rodriguez-Henche N, Garcia-Lopez E, et al. Receptors for pituitary adenylate cyclase activating peptide in human liver. J Clin Endocrinol Metab, 1995, 80 (8): 2451-2457
18. Constance L C, Anthony K. Pituitary adenylate cyclase activating polypeptide: control of rat pineal cyclic AMP and melatonin but not cyclic GMP. J Neurochem, 1995, 64 (5): 2111-2117
19. Borboni P, Porzio O, Pierucci D, et al. Molecular and functional characterization of pituitary adenylate cyclase activating polypeptide (PACAP) /vasoactive intestinal polypeptide receptors in pancreatic beta cells and effects of PACAP-38 in components of the insulin secretory system. Endocrinology, 1999, 140 (12): 5530-5537
20. Delgado M, Ganea D. Vasoactive intestinal peptide and pituitary adenylate cyclase activiting polypeptide inhibit antigen induced apoptosis of mature T lymphocytes by inhiting fas ligand expression. J Immunol, 2000, 164 (3): 1200-1210
21. Delgado M, Munoz-Elias E J, Gomariz R P, et al. Vasoactive intestinal peptide and pituitary adenylate cyclase activating polypeptide enhance IL-10 production by murine macrophages: in vitro and in vivo studies. J Immunol, 1999, 162 (3): 1707-1716